scispace - formally typeset
L

Laura P. Hale

Researcher at Duke University

Publications -  134
Citations -  12034

Laura P. Hale is an academic researcher from Duke University. The author has contributed to research in topics: T cell & Immune system. The author has an hindex of 55, co-authored 132 publications receiving 11100 citations. Previous affiliations of Laura P. Hale include Fred Hutchinson Cancer Research Center & Harvard University.

Papers
More filters
Journal ArticleDOI

Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.

TL;DR: The composition and spatial organization of the mucosal flora in biopsy specimens from patients with inflammatory bowel disease, self-limiting colitis, irritable-bowel syndrome, and healthy controls were investigated by using a broad range of fluorescent bacterial group-specific rRNA-targeted oligonucleotide probes.
Journal ArticleDOI

The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.

TL;DR: These data show a selective in vivo requirement for Glut1 in metabolic reprogramming of CD4 T cell activation and Teff expansion and survival and a selection of Treg cells that appeared functionally unaffected and able to suppress Teff, irrespective of Glut 1 expression.
Journal ArticleDOI

CD44 — A molecule involved in leukocyte adherence and T-cell activation

TL;DR: This review brings together numerous divergent lines of investigation on the CD44 molecule, review the many functional roles attributed to it, and presents a unifying view of how, with numerous ligands, it may participate in several areas of normal immune cell function.
Journal Article

Monoclonal Antibodies against EGFRvIII Are Tumor Specific and React with Breast and Lung Carcinomas and Malignant Gliomas

TL;DR: Five specific monoclonal antibodies (mAbs) developed through long-term immunization protocols using the EGFRvIII-specific synthetic peptide and the intact variant in different formats that maintained secondary and tertiary conformation are reported, establishing that EGfrvIII is truly tumor specific for subsets of breast carcinomas and for previously reported non-small cell lung carcinomas